Torino, C.; Carbone, F.; Pizzini, P.; Mezzatesta, S.; D’Arrigo, G.; Gori, M.; Liberale, L.; Moriero, M.; Michelauz, C.; Frè, F.;
et al. Osteopontin and Clinical Outcomes in Hemodialysis Patients. Biomedicines 2024, 12, 2605.
https://doi.org/10.3390/biomedicines12112605
AMA Style
Torino C, Carbone F, Pizzini P, Mezzatesta S, D’Arrigo G, Gori M, Liberale L, Moriero M, Michelauz C, Frè F,
et al. Osteopontin and Clinical Outcomes in Hemodialysis Patients. Biomedicines. 2024; 12(11):2605.
https://doi.org/10.3390/biomedicines12112605
Chicago/Turabian Style
Torino, Claudia, Federico Carbone, Patrizia Pizzini, Sabrina Mezzatesta, Graziella D’Arrigo, Mercedes Gori, Luca Liberale, Margherita Moriero, Cristina Michelauz, Federica Frè,
and et al. 2024. "Osteopontin and Clinical Outcomes in Hemodialysis Patients" Biomedicines 12, no. 11: 2605.
https://doi.org/10.3390/biomedicines12112605
APA Style
Torino, C., Carbone, F., Pizzini, P., Mezzatesta, S., D’Arrigo, G., Gori, M., Liberale, L., Moriero, M., Michelauz, C., Frè, F., Isoppo, S., Gavoci, A., Rosa, F. L., Scuricini, A., Tirandi, A., Ramoni, D., Mallamaci, F., Tripepi, G., Montecucco, F.,
& Zoccali, C.
(2024). Osteopontin and Clinical Outcomes in Hemodialysis Patients. Biomedicines, 12(11), 2605.
https://doi.org/10.3390/biomedicines12112605
